Abstract
Visceral leishmaniasis (VL) or kala-azar, an endemic vector-borne disease, affects populations in the lowest socioeconomic strata living in rural areas on the Indian subcontinent —a group that has limited access to proper health care. Untreated, kala-azar is almost always fatal, and the drugs currently in use are quite toxic. Confirmation of diagnosis before starting therapy is therefore crucial. Early diagnosis and treatment are a key strategy of the Kala-azar Elimination Programme launched in 2005 in Bangladesh , India, and Nepal. VL care must be decentralized to primary health centers to achieve this goal, which has become possible with the availability of rapid diagnostic tests. Parasitological diagnosis is limited to referral hospitals and specialized VL treatment centers. Two serological tests for field use—the direct agglutination test and the rK39 immunochromatographic test (ICT)—have both shown excellent performance on the Indian subcontinent, but the latter is preferred, because it is simpler to use. The proper implementation of these diagnostic strategies within the VL elimination programme involves not only the procurement, training, and supervision of staff, but also quality control both before and after deployment in the field. The logistical requirements are enormous, and therefore standardized guidelines for procurement and quality control must be established.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7:e35671.
Boelaert M, Meheus F, Sanchez A, et al. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Trop Med Int Health. 2009;14:639–44.
http://www.searo.who.int/mediacentre/events/striving-for-elimination-kala-azar-story/en/.
Alam MZ, Kuhls K, Schweynoch C, Sundar S, Rijal S, et al. Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent. Infection Genetics and Evolution. 2009;9:24–31.
Sundar S, More DK, Singh MK, et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the centre of the Indian epidemic. Clin Infect Dis. 2000;31:1104–7.
Collin S, Davidson R, Ritmeijer K, et al. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin Infect Dis. 2004;38:612–9.
Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health. 2001;6:849–54.
Rijal S, Chappuis F, Singh R, et al. Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline. Trans R Soc Trop Med Hyg. 2003;97:350–4.
Rijal S, Bhandari S, Koirala S, et al. Clinical risk factors for therapeutic failure in Kala azar patients treated with pentavalent antimonials in Nepal. Trans R Soc Trop Med Hyg. 2010;104:225–9.
Bhattacharya SK, Sur D, Sinha PK, Karbwang J. Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable. Indian J Med Res. 2006;123:195–6.
Sundar S, Reed SG, Singh VP, et al. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet. 1998;351:563–5.
Zhou XH, Obuchowski NA, McClish DK. The design of diagnostic accuracy studies in statistical methods in diagnostic medicine. In: Zhou XH, Obuchowski NA, & McClish DK, editors. Wiley, New York 2002, pp. 57–99.
Chappuis F, Rijal S, Singh R, Acharya P, Karki BMS, Das ML, et al. Prospective evaluation and comparison of the direct agglutination test and an rK39-antigen-based dipstick test for the diagnosis of suspected kala-azar in Nepal. Trop Med Int Health. 2003;8(3):277–85.
Chappuis F, Rijal S, Jha UK, Desjeux P, et al. Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal. Trop Med Int Health. 2006;11:31–40.
Boelaert M, Rijal S, Regmi S, et al. A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. Am J Trop Med Hyg. 2004;70:72–7.
Napier LE. A new serum test for kala-azar. Indian J Med Res. 1992;9:830–46.
WHO Technical Report Series 949. Control of the leishmaniasis: report of a WHO expert committee. World Health Organization, Geneva 2010.
Deborggraeve S, Boelaert M, Rijal S, et al. Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease. Trop Med Int Health. 2008;13:1378–83.
Reithinger R, Dujardin JC. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol. 2007;45:21–5.
Deborggraeve S, Laurent T, Espinosa D, et al. A simplified and standardized polymerase chain reaction format for the diagnosis of leishmaniasis. J Infect Dis. 2008;198:1565–72.
El Harith A, Kolk AHJ, Kager PA, et al. A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1986;80:583–6.
Chappuis F, Rijal S, Soto A, et al. A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. Br Med J. 2006;1(333):723–6.
Jacquet D, Boelaert M, Seaman J, Rijal S, et al. Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL). Trop Med Int Health. 2006;11:1777–84.
Boelaert M, Verdonck K, Menten J, Sunyoto T, van Griensven J, Chappuis F, Rijal S. Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease. Cochrane Database Syst Rev. 2014;6:CD009135.
Bhattacharyya T, Bowes DE, et al. Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis. PLoS Negl Trop Dis. 2014;8(2):e2675.
Mohapatra TM, Singh DP, Sen MR, Bharti K, Sundar S. Compararative evaluation of rK9, rK26 and rK39 antigens in the serodiagnosis of Indian visceral leishmaniasis. J Infect Dev Ctries. 2010;4(2):114–7.
Mbui J, Wasunna M, Balasegaram M, Laussermayer A, Juma R, et al. Validation of two rapid diagnostic tests for visceral leishmaniasis in Kenya. PLoS Negl Trop Dis. 2013;7(9):e2441.
Cunningham J, Hasker E, Das P, et al. WHO/TDR Visceral Leishmaniasis Laboratory Network. A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis. 2012;55(10):1312–9.
Kumar D, Khanal B, Tiwary P, et al. Comparative evaluation of blood and serum samples in rapid immunochromatographic tests for visceral leishmaniasis. J Clin Microbiol. 2013;51(12):3955–9.
Ghosh P, Hasnain MG, Ghosh D, et al. A comparative evaluation of the performance of commercially available rapid immunochromatographic tests for the diagnosis of visceral leishmaniasis in Bangladesh. Parasit Vectors. 2015;16(8):331.
Bern C, Hightower AW, Chowdhury R, et al. Risk factors for kala-azar in Bangladesh. Emerg Infect Dis. 2005;11(5):655–62.
De Almeida Silva L, Romero HD, Prata A, et al. Immunologic tests in patients after clinical cure of visceral leishmaniasis. Am J Trop Med Hyg. 2006;75:739–43.
Rijal S, Uranw S, Chappuis F, et al. The epidemiology of Leishmania donovani infection in high transmission foci in Nepal. Trop Med Int Health. 2009;14:60.
Sundar S, Gidwani K, Anderson E, et al. The epidemiology of Leishmania donovani infection in high transmission foci in India. Trop Med Int Health. 2009 Sep; 14:186.
Bhattacharyya T, Ayandeh A, Falconar et al. IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test. PLoS Negl Trop Dis. 2014 Oct 23;8(10):e3273.
Attar ZJ, Chance ML, el-Safi S, et al. Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Tropica 2001;78:11–6.
Sarkari B, Chance M, Hommel M. Antigenuria in visceral leishmaniasis: detection and partial characterisation of a carbohydrate antigen. Acta Trop. 2002;82:339–48.
Rijal S, Boelaert M, Regmi S, et al. Evaluation of urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal. Trop Med Int Health. 2004;9:724–9.
Sundar S, Singh RK, Bimal SK, et al. Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study. Trop Med Int Health. 2007;12:284–9.
El-Safi SH, Abdel-Haleem A, Hammad A, et al. Field evaluation of latex agglutination test for detecting urinary antigens in visceral leishmaniasis in Sudan. Eastern Mediterr Health J. 2003;9:844–55.
Mondal D, Singh SP, Kumar N, et al. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Neglected Trop Dis. 2009;3:e355.
Sharma AD, Bern C, Varghese B, et al. The economic impact of visceral leishmaniasis on households in Bangladesh. Trop Med Int Health. 2006;11:757–64.
Rijal S, Koirala S, Van der stuyft P, Boelaert M. The economic burden of visceral leishmaniasis for households in Nepal. Trans R Soc Trop Med Hyg. 2006;100:838–841.
Adhikari AR, Maskey NM, Sharma BP. Paying for hospital-based care of kala-azar in Nepal: assessing catastrophic, impoverishment and economic consequences. Health Policy and Planning. 2008;24:129–39.
Sundar S, Maurya R, Singh RK, et al. Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody. J Clin Microbiol. 2006;44:251–3.
Sundar S, Singh RK, Maurya R, et al. Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip test. Trans R Soc Trop Med Hyg. 2006;100:533–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing
About this chapter
Cite this chapter
Rijal, S., Chappuis, F., Alvar, J., Boelaert, M. (2016). Challenges in the Diagnosis of Visceral Leishmaniasis on the Indian Subcontinent. In: Noiri, E., Jha, T. (eds) Kala Azar in South Asia. Springer, Cham. https://doi.org/10.1007/978-3-319-47101-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-47101-3_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43611-1
Online ISBN: 978-3-319-47101-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)